Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir
HTML
Details
Locations
Year:
1998
Type:
article
Source:
The Journal of Clinical Pharmacology
DOI:
10.1002/j.1552-4604.1998.tb04398.x
Authors:
Lisa L. von Moltke,
David J. Greenblatt,
Jeffrey M. Grassi,
Brian W. Granda,
Su Xiang Duan,
Steven M. Fogelman,
Johanna P. Daily,
Jerold S. Harmatz,
Richard I. Shader
show all 9
Institutions:
Tufts University,
Tufts Medical Center,
American College of Neuropsychopharmacology,
Brigham and Women's Hospital,
Harvard University
Language:
English
Topic:
Pharmacogenetics and Drug Metabolism
Subfield:
Pharmacology
Field:
Pharmacology, Toxicology and Pharmaceutics
Domain:
Life Sciences
Keywords:
protease inhibitors,
ritonavir,
cytochrome P450 inhibition,
drug interactions,
CYP3A,
CYP2C9,
CYP2C19,
CYP2D6,
CYP1A2,
CYP2E1,
indinavir,
nelfinavir,
saquinavir,
antiretroviral drugs,
dextromethorphan O-demethylation,
liver microsomes
show all 16
SDG:
Good health and well-being
Open Access status:
closed
Funders:
National Institute of Mental Health,
National Center for Research Resources
Awards:
G2086807074,
GENERAL CLINICAL RESEARCH CENTER,
TRAINING IN GERIATRIC PSYCHOPHARMACOLOGY
OpenAlex ID:
W2009856823
FWCI:
16.55
Cites:
32
Cited by:
263
Related to:
9